Adema GJ - Search Results

1

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ. Grauer OM, et al. Among authors: adema gj. Int J Cancer. 2007 Jul 1;121(1):95-105. doi: 10.1002/ijc.22607. Int J Cancer. 2007. PMID: 17315190

2

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. Int J Cancer. 1995 Jul 4;62(1):97-102. doi: 10.1002/ijc.2910620118. Int J Cancer. 1995. PMID: 7541395 Free article.

3

Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.

Bakker AB, van der Burg SH, Huijbens RJ, Drijfhout JW, Melief CJ, Adema GJ, Figdor CG. Bakker AB, et al. Among authors: adema gj. Int J Cancer. 1997 Jan 27;70(3):302-9. doi: 10.1002/(sici)1097-0215(19970127)70:3<302::aid-ijc10>3.0.co;2-h. Int J Cancer. 1997. PMID: 9033632 Free article.

4

Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.

Schreurs MW, de Boer AJ, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: adema gj. Cancer Res. 1998 Jun 15;58(12):2509-14. Cancer Res. 1998. PMID: 9635569

5

Human melanoma therapy in the SCID mouse: in vivo targeting and reactivation of melanoma-specific cytotoxic T cells by bi-specific antibody fragments.

Cochlovius B, Perschl A, Adema GJ, Zöller M. Cochlovius B, et al. Among authors: adema gj. Int J Cancer. 1999 May 5;81(3):486-93. doi: 10.1002/(sici)1097-0215(19990505)81:3<486::aid-ijc25>3.0.co;2-p. Int J Cancer. 1999. PMID: 10209966

6

Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.

Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: adema gj. Cancer Res. 1999 Jul 15;59(14):3340-5. Cancer Res. 1999. PMID: 10416590

7

Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.

Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ. Schreurs MW, et al. Among authors: adema gj. Cancer Res. 2000 Dec 15;60(24):6995-7001. Cancer Res. 2000. PMID: 11156402

8

Renal cell carcinoma-associated antigen G250 encodes a naturally processed epitope presented by human leukocyte antigen-DR molecules to CD4(+) T lymphocytes.

Vissers JL, De Vries IJ, Engelen LP, Scharenborg NM, Molkenboer J, Figdor CG, Oosterwijk E, Adema GJ. Vissers JL, et al. Among authors: adema gj. Int J Cancer. 2002 Aug 1;100(4):441-4. doi: 10.1002/ijc.10518. Int J Cancer. 2002. PMID: 12115527

9

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells.

Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, Hartung T, Adema G, Kullberg BJ. Netea MG, et al. J Immunol. 2004 Mar 15;172(6):3712-8. doi: 10.4049/jimmunol.172.6.3712. J Immunol. 2004. PMID: 15004175

10

In situ tumor ablation creates an antigen source for the generation of antitumor immunity.

den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ, Adema GJ. den Brok MH, et al. Among authors: adema gj. Cancer Res. 2004 Jun 1;64(11):4024-9. doi: 10.1158/0008-5472.CAN-03-3949. Cancer Res. 2004. PMID: 15173017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters